$6.53
0.182.83%
Ultimo aggiornamento: Nov 26, 2:32 PM
Silence Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Silence Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
SLN | Silence Therapeutics | $0.27 | -$0.41 | — | — | $24.86M | $6.63M | — | — | 02/26/2026 | |
SLN | Silence Therapeutics | -$0.25 | -$0.28 | -$0.45 | -60.71% | $1.50M | $4.41M | $159.00K | -96.40% | 11/06/2025 | |
SLN | Silence Therapeutics | -$0.42 | -$0.23 | -$0.57 | -147.83% | $756.00K | $5.43M | $224.00K | -95.87% | 08/07/2025 | |
SLN | Silence Therapeutics | -$0.05 | — | -$0.60 | — | $15.73M | — | $142.00K | — | 05/08/2025 | |
SLN | Silence Therapeutics | -$0.16 | — | $0.27 | — | $2.61M | — | $24.86M | — | 02/27/2025 | |
SLN | Silence Therapeutics | -$0.09 | — | -$0.75 | — | $3.54M | — | $1.49M | — | 11/14/2024 | |
SLN | Silence Therapeutics | -$9.60 | — | -$0.42 | — | $9.10M | — | $754.50K | — | 08/15/2024 | |
SLN | Silence Therapeutics | -$0.12 | — | -$0.05 | — | $13.81M | — | $15.73M | — | 05/16/2024 | |
SLN | Silence Therapeutics | -$0.15 | — | -$0.16 | — | $5.59M | — | $2.61M | — | 03/13/2024 | |
SLN | Silence Therapeutics | -$0.08 | — | -$0.09 | — | $3.97M | — | $3.54M | — | 11/14/2023 | |
SLN | Silence Therapeutics | — | — | -$0.12 | — | $4.58M | — | $11.38M | — | 08/16/2023 | |
SLN | Silence Therapeutics | -$0.12 | — | -$0.12 | — | $7.68M | — | $13.81M | — | 05/16/2023 | |
SLN | Silence Therapeutics | -$0.14 | — | -$0.15 | — | $4.60M | — | $5.59M | — | 03/15/2023 | |
SLN | Silence Therapeutics | — | — | -$0.08 | — | — | — | $3.97M | — | 11/10/2022 | |
SLN | Silence Therapeutics | — | — | — | — | — | — | — | — | 08/11/2022 | |
SLN | Silence Therapeutics | — | — | -$0.12 | — | — | — | $7.68M | — | 05/16/2022 | |
SLN | Silence Therapeutics | — | — | -$0.14 | — | — | — | $4.60M | — | 03/17/2022 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.45 | $-0.28 | -60.7 % |
| Q2 | 2025-08-07 | $-0.57 | $-0.23 | -147.8 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $159.00K | $4.41M | -96.4 % |
| Q2 | 2025-08-07 | $224.00K | $5.43M | -95.9 % |
Si prevede che Silence Therapeutics (SLN) fornisca risultati il febbraio 26, 2026. Gli ultimi risultati sono stati pubblicati il novembre 6, 2025 per il Q3.
L'EPS effettivo era $-0.45, che mancato la stima di $-0.28.
Le entrate effettive sono state $159K, che mancato la stima di $4.4M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.